Year ended 28 February 2025 | Year ended 29 February 2024 | |
£’000 | £’000 | |
Interest receivable on bank balances | 1 | 183 |
Interest receivable on Money Market funds | 1,023 | 403 |
Loan interest | 72 | 96 |
Total investment income | 1,096 | 682 |
Year ended 28 February 2025 | Year ended 29 February 2024 | |||||
Revenue £’000 | Capital £’000 | Total £’000 | Revenue £’000 | Capital £’000 | Total £’000 | |
Investment management fees | 139 | 1,250 | 1,389 | 102 | 922 | 1,024 |
Year ended 28 February 2025 £’000 | Year ended 29 February 2024 £’000 | |
Financial and regulation costs | 193 | 133 |
General administration | 29 | 56 |
Fees payable to the Company’s auditor for audit services | 84 | 75 |
Company secretarial services | 24 | 24 |
Other professional fees | 465 | 344 |
Directors’ fees | 75 | 71 |
Interest payable | – | 1 |
Total operating expenses | 870 | 704 |
Year ended 28 February 2025 £’000 | Year ended 29 February 2024 £’000 | |
Fees payable to the Company’s auditor: | ||
for the audit of the Financial Statements | 84 | 75 |
for other services | – | – |
Total Auditor remuneration | 84 | 75 |
Year ended 28 February 2025 £’000 | Year ended 29 February 2024 £’000 | |
Julian Bartlett | 22 | 22 |
Jamie Brooke* | 23 | 15 |
Sam Smith** | 20 | 1 |
Chad Murrin*** | – | 8 |
Jane Owen**** | 10 | 25 |
Total Directors’ fees | 75 | 71 |
Year ended 28 February 2025 £’000 | Year ended 29 February 2024 £’000 | |
Profit/(loss) on ordinary activities before tax | 636 | (785) |
Corporation tax @ 25% | 159 | (196) |
Effect of: | ||
Capital gains not taxable | (449) | (65) |
Disallowed expenditure | 28 | 21 |
Excess management expenses on which deferred tax not recognised | 262 | 240 |
Tax charge/(credit) for the period | – | – |
Cost | Cumulative Gains | Fair Value | |
£’000 | £’000 | £’000 | |
Year ended 28 February 2025: | |||
Opening cost | 38,896 | – | 38,896 |
Opening investment holding gains | – | 4,928 | 4,928 |
Opening value at 1 March 2024 | 38,896 | 4,928 | 43,824 |
Purchases at cost* | 9,905 | – | 9,905 |
Net gains on held investments | – | 1,373 | 1,373 |
Less: investments disposed of during the period | |||
Original cost | (4,010) | – | (4,010) |
Derecognition of unrealised net cumulative losses | – | 1,219 | 1,219 |
Closing value at 28 February 2025 | 44,791 | 7,520 | 52,311 |
Cost | Cumulative Gains | Fair Value | |
£’000 | £’000 | £’000 | |
Year ended 29 February 2024: | |||
Opening Cost | 27,762 | – | 27,762 |
Opening investment holding gains | – | 4,217 | 4,217 |
Opening fair value at 1 March 2023 | 27,762 | 4,217 | 31,979 |
Purchases at cost | 11,884 | – | 11,884 |
Net gains on held investments | – | 261 | 261 |
Less: investments disposed of during the period | |||
Original cost | (750) | – | (750) |
Derecognition of unrealised net cumulative losses | – | 450 | 450 |
Closing value at 29 February 2024 | 38,896 | 4,928 | 43,824 |
Name | Registered address | Holding |
Green Highland Shenval Limited | Q Court, 3 Quality Street, Edinburgh, EH4 5BP | 22.2% |
28 February 2025 £’000 | 29 February 2024 £’000 | |
Accrued income | 38 | 23 |
Prepaid expenses | 33 | 42 |
Other debtors | 2,308 | 291 |
Total receivables | 2,379 | 356 |
28 February 2025 £’000 | 29 February 2024 £’000 | |
Cash at bank | 7,988 | 18 |
Money Market funds | 20,613 | 18,181 |
Total cash and cash equivalents | 28,601 | 18,199 |
28 February 2025 £’000 | 29 February 2024 £’000 | |
Trade Creditors | 46 | 88 |
Other taxation and social security | 5 | 6 |
Accrued expenses | 537 | 389 |
Total payables and accrued expenses | 588 | 483 |
No. of Venture Shares | Amount £'000 | |
As at 1 March 2024 | 63,113,620 | 631 |
Allotted during the period | ||
5 March 2024 | 879,639 | 9 |
18 March 2024 (DRIS) | 241,772 | 2 |
2 April 2024 | 3,769,252 | 38 |
4 April 2024 | 1,954,264 | 20 |
5 April 2024 | 1,285,315 | 13 |
27 June 2024 | 1,365,747 | 14 |
31 July 2024 | 705,100 | 7 |
29 October 2024 | 3,451,232 | 34 |
12 November 2024 | 1,818,892 | 18 |
2 December 2024 (DRIS) | 278,603 | 3 |
19 December 2024 | 3,537,826 | 35 |
10 February 2025 | 3,183,619 | 32 |
26 February 2025 | 2,465,470 | 25 |
Shares bought back and cancelled | ||
4 July 2024 | (367,609) | (4) |
9 August 2024 | (55,800) | (1) |
18 November 2024 | (84,409) | (1) |
Ordinary Share Capital 28 February 2025 | 87,542,533 | 875 |
No. of Venture Shares | No. of A Shares | No. of B Shares | Total Shares | Amount £'000 | |
As at 1 March 2023 | 42,720,246 | 9,777,285 | 6,758,795 | 59,256,326 | 593 |
Allotted during the period | |||||
20 March 2023 | 5,831,295 | – | – | 5,831,295 | 58 |
4 April 2023 | 2,093,574 | – | – | 2,093,574 | 21 |
5 April 2023 | 464,579 | – | – | 464,579 | 5 |
24 April 2023 | 161,021 | – | – | 161,021 | 2 |
6 July 2023 | 1,138,499 | – | – | 1,138,499 | 11 |
28 July 2023 | 1,347,801 | – | – | 1,347,801 | 13 |
4 September 2023 (DRIS) | 210,732 | – | – | 210,732 | 2 |
27 October 2023 | 1,124,122 | – | – | 1,124,122 | 11 |
30 November 2023 | 2,118,892 | – | – | 2,118,892 | 21 |
21 December 2023 | 1,673,802 | – | – | 1,673,802 | 17 |
13 February 2024 | 4,247,195 | – | – | 4,247,195 | 42 |
Shares bought back and cancelled | |||||
10 March 2023 | – | (9,777,285) | – | (9,777,285) | (97) |
10 March 2023 | – | – | (6,758,795) | (6,758,795) | (68) |
4 August 2023 | (6,958) | – | – | (6,958) | – |
3 November 2023 | (10,306) | – | – | (10,306) | – |
12 December 2023 | (874) | – | – | (874) | – |
Ordinary Share Capital 29 February 2024 | 63,113,620 | – | – | 63,113,620 | 631 |
Year ended 28 February 2025 £’000 | Year ended 29 February 2024 £’000 | |
Year ended 29 Feb 2024 interim dividend: 2.00p per share | – | 1,075 |
Year ended 28 Feb 2025 interim dividend: 2.00p per share | 1,262 | – |
Year ended 28 Feb 2025 interim dividend: 2.00p per share | 1,563 | – |
Total dividend paid: |
2,825 | 1,075 |
Total value | Financial Assets at amortised cost | Financial Liabilities at amortised cost | Fair value through profit or loss | |
£’000 | £’000 | £’000 | £’000 | |
Year ended 28 February 2025 | ||||
Assets: | ||||
Financial assets at fair value through profit or loss | 52,311 | – | – | 52,311 |
Receivables | 2,379 | 2,379 | – | – |
Cash and cash equivalents | 28,601 | 28,601 | – | – |
83,291 | 30,980 | – | 52,311 | |
Liabilities: | ||||
Other Payables | 588 | – | 588 | – |
588 | – | 588 | – | |
Year ended 29 February 2024 | ||||
Assets: | ||||
Financial assets at fair value through profit or loss | 43,824 | – | – | 43,824 |
Receivables | 356 | 356 | – | – |
Cash and cash equivalents | 18,199 | 18,199 | – | – |
62,379 | 18,555 | – | 43,824 | |
Liabilities: | ||||
Other Payables | 483 | – | 483 | – |
483 | – | 483 | – |
28 February 2025 £’000 | 29 February 2024 £’000 | |
Cash on Deposit | 7,988 | 19 |
Money Market funds | 20,613 | 18,180 |
28,601 | 18,199 |
28 February 2025 £’000 | 29 February 2024 £’000 | |
Non-Qualifying investment loans | 172 | 172 |
Qualifying investment loans | 2,444 | 1,076 |
Cash on Deposit | 7,988 | 19 |
Money Market funds | 20,613 | 18,180 |
Receivables | 2,379 | 356 |
33,596 | 19,803 |
28 February 2025 | Total | 1-3 months | 3-12 months | 1-2 years | 2-5 years | More than 5 years |
£’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Trade creditors | 46 | 46 | – | – | – | – |
Other taxation | 5 | 5 | – | – | – | – |
Accruals | 537 | – | 537 | – | – | – |
588 | 51 | 537 | – | – | – |
29 February 2024 | Total | 1-3 months | 3-12 months | 1-2 years | 2-5 years | More than 5 years |
£’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Trade creditors | 88 | 88 | – | – | – | – |
Other taxation | 6 | 6 | – | – | – | – |
Accruals | 389 | – | 389 | – | – | – |
483 | 94 | 389 | – | – | – |
Year ended 28 February 2025 | Year ended 29 February 2024 | |
Net asset value per Venture Share (p) | 95.44 | 98.55 |